Back to Results
First PageMeta Content
HPV vaccine / Human papillomavirus / Cervarix / Cervical cancer / Papillomaviridae / Vaginal intraepithelial neoplasia / Cervical intraepithelial neoplasia / HPV-positive oropharyngeal cancer / Gardasil / Papillomavirus / Medicine / Oncology


Statistical Review and Evaluation - Resubmission - Cervarix, November 30, 2009
Add to Reading List

Open Document

File Size: 1,19 MB

Share Result on Facebook

City

Havrix / /

Company

IgG / GlaxoSmithKline Biologicals / Glaxosmithkline plc / /

Continent

North America / Europe / /

Country

United States / /

Event

FDA Phase / /

IndustryTerm

prevention of cervical cancer / /

MedicalCondition

cervical intraepithelial neoplasia / Hepatitis A / cancer / persistent infection / CIN / infection / HPV / squamous cell cancer / cervical cancer / spontaneous abortion / infections / incident infection / adenocarcinoma / /

MedicalTreatment

vaccinations / vaccination / /

Organization

FDA CR / /

Person

Robin Levis / D. Helen Gemignani / Martha Lee / A. Dale Horne / Nancy Miller / /

Position

Chair / BLA Committee / Chair / P.H. Chief / Project Manager / Executive / /

Product

HFM-485 / HPV-008 / HPV-007 / /

Region

Latin America / Asia Pacific / /

Technology

alpha / antibodies / /

SocialTag